20.109(F12) Pre-Proposal: Engineering Viral Magnetic Nanoparticles for Magnetic Hyperthermic Cancer Therapy: Difference between revisions
Joanna Yeh (talk | contribs) |
No edit summary |
||
| Line 16: | Line 16: | ||
==Introduction== | ==Introduction== | ||
The field of magnetic hyperthermia has attracted a lot of attention in the past thirty years as an alternative cancer therapy method. Magnetic hyperthermia proposes the placement of magnetic nanoparticles (MNP) in tumor cells under an alternating magnetic field. Nanoparticles often have unique physical and chemical properties that can be varied based on size and shape. MNPs are no different; these nanoparticles are superparamagnetic, gaining magnetic properties in the presence of a magnetic field. As the direction of the magnetic field alternates, MNPs undergo magnetic hysteresis losses that are dissipated to local surroundings as thermal energy. Targeted sites usually are heated to temperatures between 42 and 45 C to cause cell damage or death. A main challenge to this method is the localization of MNPs to targeted tumor cells. | The field of magnetic hyperthermia has attracted a lot of attention in the past thirty years as an alternative cancer therapy method. Magnetic hyperthermia proposes the placement of magnetic nanoparticles (MNP) in tumor cells under an alternating magnetic field. Nanoparticles often have unique physical and chemical properties that can be varied based on size and shape. MNPs are no different; these nanoparticles are superparamagnetic, gaining magnetic properties in the presence of a magnetic field. As the direction of the magnetic field alternates, MNPs undergo magnetic hysteresis losses that are dissipated to local surroundings as thermal energy. Targeted sites usually are heated to temperatures between 42 and 45 C to cause cell damage or death. A main challenge to this method is the localization of MNPs to targeted tumor cells. How can we lower the applied dosage of MNPs in this method of cancer treatment? In other words, how can we concentrate MNPs within tumor cells to produce sufficient heat for complete cell apoptosis? | ||
References: <font color = red> Please correct the references formatting </font> | References: <font color = red> Please correct the references formatting </font> | ||
# A.J. Giustini, A.A. Petryk, S.M. Cassim, J.A. Tate, I. Baker, P.J. Hoopes. Magnetic nanoparticle hyperthermia in cancer treatment. Nano LIFE | # A.J. Giustini, A.A. Petryk, S.M. Cassim, J.A. Tate, I. Baker, P.J. Hoopes. Magnetic nanoparticle hyperthermia in cancer treatment. Nano LIFE 2010; 01: 17. | ||
# | # D. Ghosh, Y. Lee, S. Thomas, A. G. Kohli, D. S. Yun, A. M. Belcher, K. A. Kelly. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat. Nanotechnol. 2012; 7 (10): 677–82. | ||
D. Ghosh, Y. Lee, S. Thomas, A. G. Kohli, D. S. Yun, A. M. Belcher, K. A. Kelly | |||
Nat. Nanotechnol. 2012 | |||
# <font color = blue> Add more references as deem appropriate </font> | # <font color = blue> Add more references as deem appropriate </font> | ||
==Your idea== | ==Your idea== | ||
Our proposed project aims to use magnetic nanoparticles (MNP) and viruses to increase the efficacy of magnetic hyperthermia. The goal is to use viral MNP complexes consisting of MNPs attached to viruses with minimal harmful effects to humans. While viral MNPs have been worked on for quite some time, their functions have been mostly limited to ''in vivo'' MRI imaging and targeted gene delivery. Using viral MNPs, our approach can potentially concentrate MNPs in targeted tumor cells, thereby achieving the level of heat necessary for effective cell apoptosis yet at the same time, lowering the minimum MNP dosage required for the treatment. | |||
<font color = red> TWO PARAGRAPHS </font color> <br> | <font color = red> TWO PARAGRAPHS </font color> <br> | ||
Revision as of 03:19, 29 November 2012
_homepage_landscape.jpg)
Investigators
- Coyin Oh
- Joanna Yeh
- T/R
- Green
Title of Proposed Project
20.109(F12) Pre-Proposal: Engineering viral magnetic nanoparticles for magnetic hyperthermic cancer therapy
Project Summary
THREE SENTENCES ONLY.
The robot is summarising the project. Key words: magnetic nanoparticles, virus, hyperthermia.
Introduction
The field of magnetic hyperthermia has attracted a lot of attention in the past thirty years as an alternative cancer therapy method. Magnetic hyperthermia proposes the placement of magnetic nanoparticles (MNP) in tumor cells under an alternating magnetic field. Nanoparticles often have unique physical and chemical properties that can be varied based on size and shape. MNPs are no different; these nanoparticles are superparamagnetic, gaining magnetic properties in the presence of a magnetic field. As the direction of the magnetic field alternates, MNPs undergo magnetic hysteresis losses that are dissipated to local surroundings as thermal energy. Targeted sites usually are heated to temperatures between 42 and 45 C to cause cell damage or death. A main challenge to this method is the localization of MNPs to targeted tumor cells. How can we lower the applied dosage of MNPs in this method of cancer treatment? In other words, how can we concentrate MNPs within tumor cells to produce sufficient heat for complete cell apoptosis?
References: Please correct the references formatting
- A.J. Giustini, A.A. Petryk, S.M. Cassim, J.A. Tate, I. Baker, P.J. Hoopes. Magnetic nanoparticle hyperthermia in cancer treatment. Nano LIFE 2010; 01: 17.
- D. Ghosh, Y. Lee, S. Thomas, A. G. Kohli, D. S. Yun, A. M. Belcher, K. A. Kelly. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat. Nanotechnol. 2012; 7 (10): 677–82.
- Add more references as deem appropriate
Your idea
Our proposed project aims to use magnetic nanoparticles (MNP) and viruses to increase the efficacy of magnetic hyperthermia. The goal is to use viral MNP complexes consisting of MNPs attached to viruses with minimal harmful effects to humans. While viral MNPs have been worked on for quite some time, their functions have been mostly limited to in vivo MRI imaging and targeted gene delivery. Using viral MNPs, our approach can potentially concentrate MNPs in targeted tumor cells, thereby achieving the level of heat necessary for effective cell apoptosis yet at the same time, lowering the minimum MNP dosage required for the treatment.
TWO PARAGRAPHS
Ultimately, we would hope to collect results on whether viral MNPs are more effective in delivering MNPs to targeted cells compared to other MNPs.
TWO PARAGRAPHS Make clear what you see is the structural hole/gap in understanding or the need, and how you propose to fill in or satisfy what you've identified. You should specify your general approach (e.g. "will screen for mutants that enhance the contrast of the bacterial photography system") but do not need to think through the precise experimental details yet. Emphasize instead what results hope to collect and how they might improve the shortcomings that you've identified as interesting.
A sketch
yaadda
